CRISPR Brief · Proof Path

From Referral to Subscribed
in 4 Clicks

Complete buyer journey — warm outreach to first-dollar conversion

For biotech scouts & VC associates

A colleague forwards you the CRISPR Brief one-pager. You read Issue Zero free. You subscribe for $10/mo. Here's exactly what happens at each step.

1
Receive the one-pager Sent to you
Attached in email · Telegram DM · LinkedIn DM
A colleague in biotech sends you the CRISPR Brief outreach one-pager — a single self-contained HTML page or URL. No login required. No form to fill. Opens in your browser.
What you see: Problem framing specific to CRISPR deal flow screening, a comparison vs. $500+/mo analysts, and two CTAs.
See the one-pager →
2
Click "Read Issue Zero Free" Sample issue
store-v2-khaki.vercel.app/crispr-brief-issue-zero.html
You land on Issue Zero — a full sample issue with a real bioRxiv paper, a real FDA filing tracker entry, and a real pipeline mover. Written for scouts and VCs. No abstract parroting — competitive framing and diligence flags.

Issue Zero covers:

  • Prime editing in sickle cell disease — competitive moat shift from "can we edit?" to "can we edit without genotoxicity?"
  • VERVE Therapeutics IND clearance — first in vivo base editor for a cardiometabolic indication
  • Beam Therapeutics manufacturing partnership — removes a key diligence question
Read Issue Zero free → See pricing & details →
3
Click "Subscribe $10/mo" — PayPal Payment
store-v2-khaki.vercel.app/crispr-brief.html
The PayPal button on crispr-brief.html processes your $10/mo. Early-bird rate locked for life for the first 200 paid subscribers. No credit card required for the free tier — but when you're ready, PayPal handles the transaction.
$10/month
Early-bird locked for life · First 200 subscribers
🔒 Pseudonymous author 📄 Issue Zero free ✉️ Cancel anytime 🔄 No credit card for free tier
Subscribe via PayPal →
4
Land on thank-you page Post-payment
store-v2-khaki.vercel.app/thank-you.html?product=CRISPR+Brief+Monthly
Your PayPal payment confirms instantly. You land on a CRISPR-specific confirmation page — your subscription is active, Issue Zero is on its way to your PayPal email, and you can read it online right now.
📬 CRISPR Brief — Subscription Confirmed
Your CRISPR Brief subscription is active. Check your inbox — Issue Zero is on its way. Biweekly paid issues begin the Thursday after your subscription date.
Read Issue Zero now →
The complete path

One-pager received → Issue Zero read free → PayPal subscribe → CRISPR thank-you page

↓   ↓   ↓   ↓

4 clicks. No forms. No review gate. Immediate delivery.

What $10/mo actually buys

→
1 bioRxiv preprint, biweekly
Fully synthesized with competitive landscape and VC framing — not just the abstract
→
1 FDA filing tracker entry, biweekly
Clinical milestone and strategic relevance for your deal screen — not just "IND cleared"
→
1 company pipeline update, biweekly
Competitive positioning and key diligence flags — what changes and what it removes from your checklist
→
Priority question submission
Request CRISPR coverage for your specific deal focus — included with paid subscription